Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.

Identifieur interne : 000116 ( PubMed/Corpus ); précédent : 000115; suivant : 000117

Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.

Auteurs : Mija Marinkovi ; Matilda Šprung ; Maja Buljubaši ; Ivana Novak

Source :

RBID : pubmed:29643976

English descriptors

Abstract

In the last two decades, accumulating evidence pointed to the importance of autophagy in various human diseases. As an essential evolutionary catabolic process of cytoplasmatic component digestion, it is generally believed that modulating autophagic activity, through targeting specific regulatory actors in the core autophagy machinery, may impact disease processes. Both autophagy upregulation and downregulation have been found in cancers, suggesting its dual oncogenic and tumor suppressor properties during malignant transformation. Identification of the key autophagy targets is essential for the development of new therapeutic agents. Despite this great potential, no therapies are currently available that specifically focus on autophagy modulation. Although drugs like rapamycin, chloroquine, hydroxychloroquine, and others act as autophagy modulators, they were not originally developed for this purpose. Thus, autophagy may represent a new and promising pharmacologic target for future drug development and therapeutic applications in human diseases. Here, we summarize our current knowledge in regard to the interplay between autophagy and malignancy in the most significant tumor types: pancreatic, breast, hepatocellular, colorectal, and lung cancer, which have been studied in respect to autophagy manipulation as a promising therapeutic strategy. Finally, we present an overview of the most recent advances in therapeutic strategies involving autophagy modulators in cancer.

DOI: 10.1155/2018/8023821
PubMed: 29643976

Links to Exploration step

pubmed:29643976

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.</title>
<author>
<name sortKey="Marinkovi, Mija" sort="Marinkovi, Mija" uniqKey="Marinkovi M" first="Mija" last="Marinkovi">Mija Marinkovi</name>
<affiliation>
<nlm:affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sprung, Matilda" sort="Sprung, Matilda" uniqKey="Sprung M" first="Matilda" last="Šprung">Matilda Šprung</name>
<affiliation>
<nlm:affiliation>Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Buljubasi, Maja" sort="Buljubasi, Maja" uniqKey="Buljubasi M" first="Maja" last="Buljubaši">Maja Buljubaši</name>
<affiliation>
<nlm:affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Novak, Ivana" sort="Novak, Ivana" uniqKey="Novak I" first="Ivana" last="Novak">Ivana Novak</name>
<affiliation>
<nlm:affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29643976</idno>
<idno type="pmid">29643976</idno>
<idno type="doi">10.1155/2018/8023821</idno>
<idno type="wicri:Area/PubMed/Corpus">000116</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000116</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.</title>
<author>
<name sortKey="Marinkovi, Mija" sort="Marinkovi, Mija" uniqKey="Marinkovi M" first="Mija" last="Marinkovi">Mija Marinkovi</name>
<affiliation>
<nlm:affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sprung, Matilda" sort="Sprung, Matilda" uniqKey="Sprung M" first="Matilda" last="Šprung">Matilda Šprung</name>
<affiliation>
<nlm:affiliation>Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Buljubasi, Maja" sort="Buljubasi, Maja" uniqKey="Buljubasi M" first="Maja" last="Buljubaši">Maja Buljubaši</name>
<affiliation>
<nlm:affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Novak, Ivana" sort="Novak, Ivana" uniqKey="Novak I" first="Ivana" last="Novak">Ivana Novak</name>
<affiliation>
<nlm:affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Oxidative medicine and cellular longevity</title>
<idno type="eISSN">1942-0994</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autophagy (physiology)</term>
<term>Humans</term>
<term>Neoplasms (pathology)</term>
<term>Neoplasms (therapy)</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Autophagy</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In the last two decades, accumulating evidence pointed to the importance of autophagy in various human diseases. As an essential evolutionary catabolic process of cytoplasmatic component digestion, it is generally believed that modulating autophagic activity, through targeting specific regulatory actors in the core autophagy machinery, may impact disease processes. Both autophagy upregulation and downregulation have been found in cancers, suggesting its dual oncogenic and tumor suppressor properties during malignant transformation. Identification of the key autophagy targets is essential for the development of new therapeutic agents. Despite this great potential, no therapies are currently available that specifically focus on autophagy modulation. Although drugs like rapamycin, chloroquine, hydroxychloroquine, and others act as autophagy modulators, they were not originally developed for this purpose. Thus, autophagy may represent a new and promising pharmacologic target for future drug development and therapeutic applications in human diseases. Here, we summarize our current knowledge in regard to the interplay between autophagy and malignancy in the most significant tumor types: pancreatic, breast, hepatocellular, colorectal, and lung cancer, which have been studied in respect to autophagy manipulation as a promising therapeutic strategy. Finally, we present an overview of the most recent advances in therapeutic strategies involving autophagy modulators in cancer.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29643976</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>09</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1942-0994</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>2018</Volume>
<PubDate>
<Year>2018</Year>
</PubDate>
</JournalIssue>
<Title>Oxidative medicine and cellular longevity</Title>
<ISOAbbreviation>Oxid Med Cell Longev</ISOAbbreviation>
</Journal>
<ArticleTitle>Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.</ArticleTitle>
<Pagination>
<MedlinePgn>8023821</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1155/2018/8023821</ELocationID>
<Abstract>
<AbstractText>In the last two decades, accumulating evidence pointed to the importance of autophagy in various human diseases. As an essential evolutionary catabolic process of cytoplasmatic component digestion, it is generally believed that modulating autophagic activity, through targeting specific regulatory actors in the core autophagy machinery, may impact disease processes. Both autophagy upregulation and downregulation have been found in cancers, suggesting its dual oncogenic and tumor suppressor properties during malignant transformation. Identification of the key autophagy targets is essential for the development of new therapeutic agents. Despite this great potential, no therapies are currently available that specifically focus on autophagy modulation. Although drugs like rapamycin, chloroquine, hydroxychloroquine, and others act as autophagy modulators, they were not originally developed for this purpose. Thus, autophagy may represent a new and promising pharmacologic target for future drug development and therapeutic applications in human diseases. Here, we summarize our current knowledge in regard to the interplay between autophagy and malignancy in the most significant tumor types: pancreatic, breast, hepatocellular, colorectal, and lung cancer, which have been studied in respect to autophagy manipulation as a promising therapeutic strategy. Finally, we present an overview of the most recent advances in therapeutic strategies involving autophagy modulators in cancer.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Marinković</LastName>
<ForeName>Mija</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Šprung</LastName>
<ForeName>Matilda</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Buljubašić</LastName>
<ForeName>Maja</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Novak</LastName>
<ForeName>Ivana</ForeName>
<Initials>I</Initials>
<Identifier Source="ORCID">0000-0003-0682-7052</Identifier>
<AffiliationInfo>
<Affiliation>School of Medicine, University of Split, Šoltanska 2, 21000 Split, Croatia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>01</Month>
<Day>31</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Oxid Med Cell Longev</MedlineTA>
<NlmUniqueID>101479826</NlmUniqueID>
<ISSNLinking>1942-0994</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>07</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>11</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>12</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>9</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29643976</ArticleId>
<ArticleId IdType="doi">10.1155/2018/8023821</ArticleId>
<ArticleId IdType="pmc">PMC5831833</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2017 Jul 14;12 (7):e0181089</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28708856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Cells. 2007 Feb;12(2):209-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17295840</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2003 Dec 15;17(24):3112-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14681207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 1992 May 1;52(9):2624-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1568230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Sci. 2011 Aug;102(8):1568-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21518141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 2005 May 9;169(3):425-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15866887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pharmacol Exp Ther. 2011 Apr;337(1):155-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21205925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Ther Pat. 2015;25(9):1003-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26013494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Neurosci. 2010 Dec;17 (12 ):1515-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20863706</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2011 Sep 2;146(5):682-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21884931</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Mol Med. 2010 Oct;14(10):2448-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19583815</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pathol. 2010 Jun;221(2):117-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20225337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterol Res Pract. 2014;2014:179586</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24723943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2017 Jul;16(7):487-511</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28529316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Exp Pathol. 2013;6(4):711-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23573318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Investig Drugs. 2002 Feb;3(2):295-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12020063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>APMIS. 2011 Nov;119(11):802-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21995634</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Biol Ther. 2013 Feb;14 (2):100-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23192274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2004 Aug 15;18(16):1926-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15314020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thorac Oncol. 2013 Jun;8(6):693-702</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23575415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastrointest Oncol. 2014 Mar 15;6(3):74-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24653797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2013 Feb 1;9(2):124-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23295650</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathol Res Pract. 2011 Jul 15;207 (7):433-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21664058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Rep. 2016 Nov;17 (11):1552-1564</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27670885</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2011 Sep;121(9):3554-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21804191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2015 Mar 30;6(9):7084-103</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25762626</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Feb 25;10 (2):e0117375</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25714809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2013 Feb 21;4:e501</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23429287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2010 Feb 5;140(3):313-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20144757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2007 Aug 17;282(33):24131-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17580304</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Biochem Cell Biol. 2011 Apr;43(4):460-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21256243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22436748</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Oct 17;9(10 ):e110293</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25329677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2010 Sep;12(9):823-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20811354</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2014 Jul 2;312(1):57-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25058218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anticancer Drugs. 2012 Aug;23(7):675-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22561420</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2009 Apr;5(3):303-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19066461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2004 Jan 22;23(3):639-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14737099</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2011 Nov 11;147(4):728-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22078875</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Ther Targets. 2016;20(4):487-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26523761</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CA Cancer J Clin. 2017 Jan;67(1):7-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28055103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1993 Oct 25;333(1-2):169-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8224160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2000 Aug 17;406(6797):747-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10963602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Ther. 2011 Sep;10(9):1533-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21878654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2013;18(11):1214-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24072220</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Pharmacol Sin. 2013 May;34(5):625-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23524572</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1989 Dec 7;342(6250):705-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2531845</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2010;15(4):428-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20332142</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2003 Jun 19;22(25):3927-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12813466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2007 Oct;9(10):1102-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17909521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Cancer. 2014 May 09;14 :327</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24885292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Jan 30;421(6922):499-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12556884</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Pathol. 2008 Jul;39(7):1059-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18495205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2008 Apr 25;30(2):214-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18439900</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Carcinogenesis. 1993 Dec;14(12):2501-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8269618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):98-106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25130795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2013 Dec 12;504(7479):296-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24305049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12017-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17609368</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Oct 1;461(7264):654-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19794493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2014 Apr;10 (4):662-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24492513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Cell. 2014 Apr;25(8):1327-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24554770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Signal. 2009 Aug 18;2(84):pe51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19690328</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2004 Jun 1;117(Pt 13):2805-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15169837</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Jul 24;359(4):378-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18650514</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2012 Sep;11(9):709-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22935804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dig Dis Sci. 2013 Oct;58(10 ):2887-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23812859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2017 Feb 10;18(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28208579</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(6):378-385</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28603209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2011 Apr 1;25(7):717-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21406549</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 2000 Nov 1;19(21):5720-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11060023</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Cell Biol. 2015 Jan;25(1):37-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25278333</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2016 Feb 2;7(5):5788-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26735341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Ther Nucleic Acids. 2017 Jun 16;7:299-313</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28624205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2017 May 16;8(20):33704-33712</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28410240</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2012 Dec 7;151(6):1256-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23217709</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2005 Oct;115(10):2679-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16200202</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Rev. 2011 Mar;240(1):92-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21349088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2014;10(12):2346-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25629933</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2000 Nov 23;408(6811):488-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11100732</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anticancer Res. 2007 May-Jun;27(3B):1453-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17595761</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(12 ):e52705</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23285162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2004 Nov;6(11):1122-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15467718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2011 Apr 15;25(8):795-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21498569</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 1985 Mar;157(1):15-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2857648</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Pharmacol Sci. 2005 Feb;26(2):69-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15681023</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2011 Feb;13(2):132-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21258367</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2010 Sep;12(9):831-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20811355</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Biol Cell. 2008 Dec;19(12 ):5360-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18843052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 1995 Mar 1;55(5):1002-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7866981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1994 May;125(3):573-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7909812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Immunol Res. 2017 May;5(5):363-375</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28351890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 2005 Nov 21;171(4):603-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16286508</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Lung Cancer. 2015 Sep;16(5):e55-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25979647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2003 Dec;112(12 ):1809-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14638851</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mod Pathol. 2010 Jul;23 (7):937-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20473282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Cell. 2003 Dec;4(6):437-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14706336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2007 Oct;9(10 ):1142-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17891140</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autophagy. 2016;12 (1):1-222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26799652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO J. 1993 Feb;12 (2):677-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8440258</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2011 Aug 13;378(9791):607-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21620466</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Rep. 2008 Sep;9(9):859-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18704115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Discov. 2013 Aug;3(8):894-907</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23650262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Cell. 2006 Jul;10 (1):51-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16843265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Mol Med. 2009 Jul;13(7):1371-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18466352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncotarget. 2016 Apr 19;7(16):21235-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26788909</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>APMIS. 2007 Dec;115(12 ):1344-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18184403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Biol Med. 2012 Jun;9(2):105-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23691463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2009 Jan;10(1):25-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19095497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Discov. 2014 Aug;4(8):905-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24875860</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Cell. 2008 Apr;13(4):343-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18394557</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2009 Jun 12;137(6):1001-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19524504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2014 Mar 26;15(4):5292-303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24675697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomaterials. 2015 Mar;44:71-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25617127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2011 Mar 1;25(5):460-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21317241</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2004 Dec 23;432(7020):1032-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15525940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2011 Jul 15;71(14):4955-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21622715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2012 Jun 20;4(139):139ra84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22539746</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genomics. 1999 Jul 1;59(1):59-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10395800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2011 Feb 10;364(6):514-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21306238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2013 Jul 1;27(13):1447-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23824538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2011 Jul 15;25(14):1510-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21764854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2009 Dec;11(12 ):1433-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19898463</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2004 Jun 1;117(Pt 13):2687-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15138286</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Cancer. 2012 Apr 26;12(6):401-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22534666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Differ. 2015 Jun;22(6):1025-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25526090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Endocrinol. 2014 Jun;10(6):322-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24663220</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2012 Oct 18;13(10):13414-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23202960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2014 Sep 11;371(11):1039-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25207767</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2011 Jan 28;331(6016):456-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21205641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Manag Res. 2010 Mar 09;2:61-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21188097</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2017 Jun 21;23 (23 ):4311-4316</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28694672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Cell Dev Biol. 2011;27:107-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21801009</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2011 Dec 16;334(6062):1573-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22174255</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2004 Sep 15;117(Pt 20):4837-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15340014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cancer Ther. 2009 Jul;8(7):2036-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19584239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drugs. 2013 Apr;73(5):475-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23529824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Cancer. 2012 Aug 1;131(3):548-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21858812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dig Liver Dis. 2012 Jul;44(7):610-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22459565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2013 Feb 07;4:e485</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23392173</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Gastroenterol. 2011 Nov 21;17 (43):4779-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22147978</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Med Insights Oncol. 2012;6:153-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22550404</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Nov 5;306(5698):990-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15528435</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 1999 Dec 9;402(6762):672-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10604474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2010 Jul;46(10 ):1900-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20231086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Support Palliat Care. 2017 Sep;11(3):231-237</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28590313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell. 2015 Jul 16;59(2):285-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26118643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2010 Apr;51(4):1237-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20187107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2014 Jan;24(1):92-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24281265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2014 Aug 18;15(8):14372-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25196438</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2012 Apr;69(7):1125-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22080117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15077-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14657337</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2014 Jun;19(6):637-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24821822</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2014 Jun 1;28(11):1204-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24888590</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2010 Sep;12(9):814-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20811353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2008 Jan 11;132(1):27-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18191218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tumour Biol. 2016 Aug;37(8):10539-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26852748</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2011 Jan 20;469(7330):323-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21248839</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Tumour Biol. 2014 Dec;35(12 ):12225-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25256671</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Pharmacother. 2010 Nov;64(9):609-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20888174</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Struct Funct. 2002 Dec;27(6):421-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12576635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2009 Jun 12;137(6):1062-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19524509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Biol. 2009 Feb 10;7(2):e38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19209957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Cell. 2004 Apr;6(4):463-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15068787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Inflammopharmacology. 2017 Jun;25(3):293-312</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28417246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1988 May 20;53(4):549-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2453289</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Chromosomes Cancer. 2010 Oct;49(10 ):901-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20589936</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Huazhong Univ Sci Technolog Med Sci. 2009 Dec;29(6):737-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20037818</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2015 Apr 23;520(7548):563-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25686604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Discov. 2013 Nov;3(11):1272-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23965987</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000116 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000116 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:29643976
   |texte=   Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:29643976" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021